Staff: Stephanie Land, PhD
Stephanie Land, PhD
Program Director, Statistician
Organization:
Contact:stephanie.land@nih.gov
240-276-6946
Stephanie Land, PhD, is a Program Director and Statistician in the Behavioral Research Program Tobacco Control Research Branch (TCRB) at the National Cancer Institute (NCI). Her areas of focus are tobacco use among patients in the settings of cancer prevention, screening, treatment, and survivorship.
Scientific Interests
- Tobacco use and cessation among cancer patients
- Tobacco use and cancer prevention and screening
- Clinical trials
Selected Publications and Presentations
- Price SN, Land SR, Pebley K, Fahey MC, Palmer AM, McCall MH, Raper PJ, Rojewski AM, Croghan IT, Wagner LI, Toll BA. Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network Trials. Nicotine Tob Res 2025 Mar 22:ntaf071.
- Streck JM, Lee JW, Walter AW, Rosen RL, Gareen IF, Kircher SM, Herman BA, Carlos RC, Kumar S, Mayer IA, Saba NF, Fenske TS, Neal JW, Atkins MB, Hodi FS, Kyriakopoulos CE, Tempany C, Shanafelt TD, Wagner LI, Land SR, Park ER, Ostroff JS. Cigarette and alternative tobacco product use among adult cancer survivors enrolled in 9 ECOG-ACRIN clinical trials. Cancer Epidemiol Biomarkers Prev 2023 Jul 6; EPI-23-0420.
- Land SR, Baker L, Twesten J, Reyes-Guzman CM, Kaufman AR. Smoking Cessation and Tobacco-Related Risk Perceptions Among People With and Without a Diagnosis of Cancer. Cancer Epidemiol Biomarkers Prev 2022 Dec 7; EPI-22-0651.
- Land SR, Baker L, Bachand J, Twesten J, Reyes-Guzman CM, Kaufman AR. Associations of Daily Versus Nondaily Smoking, Tobacco-Related Risk Perception, and Cancer Diagnosis Among Adults in the Population Assessment of Tobacco and Health (PATH) Study. Nicotine Tob Res 2022 Oct 17; 24(10):1540-1547.
- Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW. Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clin Cancer Res 2016 Apr 15; 22(8):1907-13.
To request edits to this profile, please contact us at ncidccpsbrpadvances@mail.nih.gov.